151 related articles for article (PubMed ID: 23771854)
1. Penetration of micafungin into the burn eschar in patients with severe burns.
Sasaki J; Yamanouchi S; Sato Y; Abe S; Shinozawa Y; Kishino S; Aikawa N; Hori S
Eur J Drug Metab Pharmacokinet; 2014 Jun; 39(2):93-7. PubMed ID: 23771854
[TBL] [Abstract][Full Text] [Related]
2. Micafungin concentrations in the plasma and burn eschar of severely burned patients.
Sasaki J; Yamanouchi S; Kudo D; Endo T; Nomura R; Takuma K; Kushimoto S; Shinozawa Y; Kishino S; Hori S; Aikawa N
Antimicrob Agents Chemother; 2012 Feb; 56(2):1113-5. PubMed ID: 22083486
[TBL] [Abstract][Full Text] [Related]
3. Effect of liver and kidney function on migafungin disposition in patients with hematologic malignancies.
Nakagawa Y; Ichii Y; Saeki Y; Kodama M; Kishino S; Suzuki K
Eur J Drug Metab Pharmacokinet; 2008; 33(3):191-8. PubMed ID: 19007046
[TBL] [Abstract][Full Text] [Related]
4. Safety, tolerability, and feasibility of antifungal prophylaxis with micafungin at 2 mg/kg daily in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation.
Yoshikawa K; Nakazawa Y; Katsuyama Y; Hirabayashi K; Saito S; Shigemura T; Tanaka M; Yanagisawa R; Sakashita K; Koike K
Infection; 2014 Aug; 42(4):639-47. PubMed ID: 24567233
[TBL] [Abstract][Full Text] [Related]
5. Comparative Population Plasma and Tissue Pharmacokinetics of Micafungin in Critically Ill Patients with Severe Burn Injuries and Patients with Complicated Intra-Abdominal Infection.
García-de-Lorenzo A; Luque S; Grau S; Agrifoglio A; Cachafeiro L; Herrero E; Asensio MJ; Sánchez SM; Roberts JA
Antimicrob Agents Chemother; 2016 Oct; 60(10):5914-21. PubMed ID: 27458229
[TBL] [Abstract][Full Text] [Related]
6. Plasma concentration of micafungin in patients with hematologic malignancies.
Nakagawa Y; Ichii Y; Saeki Y; Kodaka M; Suzuki K; Kishino S
J Infect Chemother; 2007 Feb; 13(1):39-45. PubMed ID: 17334728
[TBL] [Abstract][Full Text] [Related]
7. Ocular distribution of intravenously administered micafungin in rabbits.
Suzuki T; Uno T; Chen G; Ohashi Y
J Infect Chemother; 2008 Jun; 14(3):204-7. PubMed ID: 18574655
[TBL] [Abstract][Full Text] [Related]
8. Distribution of micafungin in the tissue fluids of patients with invasive fungal infections.
Yamada N; Kumada K; Kishino S; Mochizuki N; Ohno K; Ogura S
J Infect Chemother; 2011 Oct; 17(5):731-4. PubMed ID: 21537970
[TBL] [Abstract][Full Text] [Related]
9. Impact of plasma exchange on pharmacokinetic disposition of micafungin.
Konishi H; Fukushima K; Saotome T; Hamamoto T; Eguchi Y; Sudo M; Sumi M; Minouchi T; Iga I; Yamaji A
Ther Apher Dial; 2010 Jun; 14(3):358-63. PubMed ID: 20609192
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of micafungin in patients undergoing allogeneic hematopoietic stem cell transplantation.
Oshima K; Kanda Y; Kako S; Ohno K; Kishino S; Kurokawa M
Transpl Infect Dis; 2013 Jun; 15(3):323-7. PubMed ID: 23578224
[TBL] [Abstract][Full Text] [Related]
11. Effect of blood decrease on micafungin disposition in rats.
Konishi H; Fukushima K; Sudo M; Sumi M; Minouchi T; Iga I; Shibata N; Yamaji A
Eur J Drug Metab Pharmacokinet; 2011 Mar; 36(1):35-9. PubMed ID: 21350921
[TBL] [Abstract][Full Text] [Related]
12. The impact of total bilirubin on plasma micafungin levels in living-donor liver transplantation recipients with severe liver dysfunction.
Muraki Y; Iwamoto T; Kagawa Y; Sakurai H; Usui M; Isaji S; Uemoto S; Okuda M
Biol Pharm Bull; 2009 Apr; 32(4):750-4. PubMed ID: 19336919
[TBL] [Abstract][Full Text] [Related]
13. Intrapulmonary pharmacokinetics and pharmacodynamics of micafungin in adult lung transplant patients.
Walsh TJ; Goutelle S; Jelliffe RW; Golden JA; Little EA; DeVoe C; Mickiene D; Hayes M; Conte JE
Antimicrob Agents Chemother; 2010 Aug; 54(8):3451-9. PubMed ID: 20439610
[TBL] [Abstract][Full Text] [Related]
14. [A liquid chromatographic method for quantifying unbound micafungin in human plasma and the relationship between the concentrations of unbound and total micafungin in plasma].
Noda K; Yokoyama T; Akiyama Y; Tadano K
Yakugaku Zasshi; 2013; 133(3):397-404. PubMed ID: 23208119
[TBL] [Abstract][Full Text] [Related]
15. Intraocular penetration of micafungin in patient with Candida albicans endophthalmitis.
Mochizuki K; Suemori S; Udo K; Komori S; Ohkusu K; Yamada N; Ogura S
J Ocul Pharmacol Ther; 2011 Oct; 27(5):531-3. PubMed ID: 21751880
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and burn eschar penetration of intravenous ciprofloxacin in patients with major thermal injuries.
Varela JE; Cohn SM; Brown M; Ward CG; Namias N; Spalding PB
J Antimicrob Chemother; 2000 Mar; 45(3):337-42. PubMed ID: 10702553
[TBL] [Abstract][Full Text] [Related]
17. Altered Micafungin Pharmacokinetics in Intensive Care Unit Patients.
Lempers VJ; Schouten JA; Hunfeld NG; Colbers A; van Leeuwen HJ; Burger DM; Verweij PE; Pickkers P; Brüggemann RJ
Antimicrob Agents Chemother; 2015 Aug; 59(8):4403-9. PubMed ID: 25963988
[TBL] [Abstract][Full Text] [Related]
18. Reduced elimination clearance of micafungin in rats with cholestatic hyperbilirubinemia.
Konishi H; Fukushima K; Sudo M; Sumi M; Minouchi T; Iga I; Shibata N; Takada K; Yamaji A
Fundam Clin Pharmacol; 2010 Aug; 24(4):457-62. PubMed ID: 19845766
[TBL] [Abstract][Full Text] [Related]
19. Population pharmacokinetics/pharmacodynamics of micafungin against Candida species in obese, critically ill, and morbidly obese critically ill patients.
Maseda E; Grau S; Luque S; Castillo-Mafla MP; Suárez-de-la-Rica A; Montero-Feijoo A; Salgado P; Gimenez MJ; García-Bernedo CA; Gilsanz F; Roberts JA
Crit Care; 2018 Apr; 22(1):94. PubMed ID: 29655372
[TBL] [Abstract][Full Text] [Related]
20. Influence of fungicidal activity against Candida tropicalis on the efficacy of micafungin and liposomal amphotericin B in a neutropenic murine lethal infection model.
Takemoto K; Nakayama T; Kanazawa K; Ueda Y
Pharmacology; 2012; 90(3-4):133-45. PubMed ID: 22847175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
